文献库搜索 | GeneLibs

Gootzen(TA),Hermens(RP),van Gelder(MM),Hei... J Natl Cancer Inst 2026-04-07

...BRCA1/2-PV carriers aged 25 to 40 (BRCA1) or 25 to 45 (BRCA2) chose RRS/DO or salpingo-oophorectomy with or without horm...

Chen(H),Zhao(Y),Hu(B),Wang(W),Song(M),Zhao... Adv Sci (Weinh) 2026-06-00

...BRCA1, RAD51C, and BAP1), establishing a generalizable framework for gene-specific VEP with potential applications in pr...

Hu(C),Sahu(S),Chen(W),Galloux(M),Richardso... Nat Commun 2026-04-09

...BRCA1/2 variant curation expert panel specifications resulted in classification of 5926 (92.8%) BRCA2 variants as pathog...

Shin(SH),Ahn(SG),Ryu(JM),Lee(SB),Park(HS),... Breast Cancer Res 2026-04-09

...BRCA1 and BRCA2 carriers (P = 0.07). Correspondence analysis revealed that, in younger patients (< 50 years) with BRCA1 ...

Sakai(H),Kusumoto-Matsuo(R),Hosonaga(M),No... Breast Cancer 2026-05-00

...BRCA1/2 reversion mutations were identified in 25.0% (2/8; 95% CI 3.2–65.1%) with germline BRCA1 mutation and 23.5% (8/3...

Davidson(B) Acta Cytol 2026-04-10

...BRCA1-associated protein 1 (BAP1) and methylthioadenosine phosphorylase (MTAP) protein expression by immunohistochemistr...

Abdulkareem(NM),Jiang(Y),Qi(Y),Liu(X),Zhan... Proc Natl Acad Sci U S A 2026-04-21

...BRCA1/2 mutations. Although PARPi are FDA approved for adjuvant treatment of locally advanced or metastatic breast cance...

Beck(MH),Kordowitzki(P),Roser(E),Trelinska... BMC Cancer 2026-04-16

...BRCA1/2 mutations. Median overall survival was not reached for patients with endometriosis-correlated ovarian tumors or ...

Ejaz(S),Raashid(A),Hameed(Y),Abdullah(I),I... J Med Case Rep 2026-04-16

...BRCA1 and protein 4. This study reveals the mutational spectrum of BRCA1 in patients with acute myeloid leukemia, repres...

Yu(HY),Lin(LG),Chao(Y),Li(CP) J Chin Med Assoc 2026-04-01

...BRCA1/2, ATM, and mismatch repair genes. Routine population screening is not recommended; instead, surveillance using en...